Clinical Trial Update: Penclomedine in Treating Patients With Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

The document reports the completed Phase 1 trial of Penclomedine in patients with lymphoma or unspecified adult solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Penclomedine (Penclomedine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: COMPLETED